190 related articles for article (PubMed ID: 15304126)
1. Diverse p53 gene aberration in hepatocellular carcinoma detected by dual-color fluorescence in situ hybridization.
Kondo M; Marusawa H; Ueda Y; Katsurada A; Kawasome C; Takami S; Kinoshita M; Ikai I; Yamaoka Y; Chiba T
J Gastroenterol Hepatol; 2004 Sep; 19(9):1066-73. PubMed ID: 15304126
[TBL] [Abstract][Full Text] [Related]
2. Analysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization.
Kobayashi M; Kawashima A; Mai M; Ooi A
Am J Pathol; 1996 Nov; 149(5):1575-84. PubMed ID: 8909247
[TBL] [Abstract][Full Text] [Related]
3. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
[TBL] [Abstract][Full Text] [Related]
4. [Loss of heterozygosity on chromosomes 17 and 16 in primary hepatocellular carcinomas].
Shao J; Li X; Liu Z
Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):428-30. PubMed ID: 11715437
[TBL] [Abstract][Full Text] [Related]
5. Numerical aberrations of chromosome 17 and the p53 locus in small hepatocellular carcinomas.
Yano H; Nanashima A; Hidaka S; Haseba M; Tanaka K; Yamaguchi H; Nakagoe T; Tagawa Y; Nagayasu T
Anticancer Res; 2004; 24(1):111-5. PubMed ID: 15015584
[TBL] [Abstract][Full Text] [Related]
6. Comparative genomic hybridization (CGH) and fluorescence in situ hybridization (FISH) in the diagnosis of hepatocellular carcinoma.
Wilkens L; Bredt M; Flemming P; Mengel M; Becker T; Klempnauer J; Kreipe H
J Hepatobiliary Pancreat Surg; 2002; 9(3):304-11. PubMed ID: 12353141
[TBL] [Abstract][Full Text] [Related]
7. p53 gene mutation spectrum in hepatocellular carcinoma.
Oda T; Tsuda H; Scarpa A; Sakamoto M; Hirohashi S
Cancer Res; 1992 Nov; 52(22):6358-64. PubMed ID: 1330291
[TBL] [Abstract][Full Text] [Related]
8. Interphase cytogenetic studies of human hepatocellular carcinomas by fluorescent in situ hybridization.
Hamon-Benais C; Ingster O; Terris B; Couturier-Turpin MH; Bernheim A; Feldmann G
Hepatology; 1996 Mar; 23(3):429-35. PubMed ID: 8617421
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.
Rashid A; Wang JS; Qian GS; Lu BX; Hamilton SR; Groopman JD
Br J Cancer; 1999 Apr; 80(1-2):59-66. PubMed ID: 10389978
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder.
Hartmann A; Schlake G; Zaak D; Hungerhuber E; Hofstetter A; Hofstaedter F; Knuechel R
Cancer Res; 2002 Feb; 62(3):809-18. PubMed ID: 11830537
[TBL] [Abstract][Full Text] [Related]
11. Comparative genomic hybridization of hepatocellular carcinoma: correlation with fluorescence in situ hybridization in paraffin-embedded tissue.
Rao UN; Gollin SM; Beaves S; Cieply K; Nalesnik M; Michalopoulos GK
Mol Diagn; 2001 Mar; 6(1):27-37. PubMed ID: 11257209
[TBL] [Abstract][Full Text] [Related]
12. Genetic aberration in primary hepatocellular carcinoma: correlation between p53 gene mutation and loss-of-heterozygosity on chromosome 16q21-q23 and 9p21-p23.
Wang G; Huang CH; Zhao Y; Cai L; Wang Y; Xiu SJ; Jiang ZW; Yang S; Zhao T; Huang W; Gu JR
Cell Res; 2000 Dec; 10(4):311-23. PubMed ID: 11191353
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas.
Cazals-Hatem D; Rebouissou S; Bioulac-Sage P; Bluteau O; Blanché H; Franco D; Monges G; Belghiti J; Sa Cunha A; Laurent-Puig P; Degott C; Zucman-Rossi J
J Hepatol; 2004 Aug; 41(2):292-8. PubMed ID: 15288479
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic analyses of hepatocellular carcinoma by in situ hybridization with a chromosome-specific DNA probe.
Kimura H; Kagawa K; Deguchi T; Nakajima T; Kakusui M; Ohkawara T; Katagishi T; Okanoue T; Kashima K; Ashihara T
Cancer; 1996 Jan; 77(2):271-7. PubMed ID: 8625234
[TBL] [Abstract][Full Text] [Related]
15. [Cytogenetic and molecular genetic alterations on chromosome 4q in human hepatocellular carcinoma].
Zhang HK; Wang HY; Xia JC
Ai Zheng; 2008 Sep; 27(9):998-1005. PubMed ID: 18799044
[TBL] [Abstract][Full Text] [Related]
16. [Analysis on loss of heterozygosity of chromosome 17p13.3 in hepatocellular carcinoma and construction of genomic contig in the deleted region].
Zhao X; Wan D; Jiang H
Zhonghua Zhong Liu Za Zhi; 2000 Sep; 22(5):377-80. PubMed ID: 11778272
[TBL] [Abstract][Full Text] [Related]
17. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.
Hosono S; Chou MJ; Lee CS; Shih C
Oncogene; 1993 Feb; 8(2):491-6. PubMed ID: 8093978
[TBL] [Abstract][Full Text] [Related]
18. Losses of chromosome arms 4q, 8p, 13q and gain of 8q are correlated with increasing chromosomal instability in hepatocellular carcinoma.
Hertz S; Rothämel T; Skawran B; Giere C; Steinemann D; Flemming P; Becker T; Flik J; Wiese B; Soudah B; Kreipe H; Schlegelberger B; Wilkens L
Pathobiology; 2008; 75(5):312-22. PubMed ID: 18931534
[TBL] [Abstract][Full Text] [Related]
19. Relationship between loss of heterozygosity of tumor suppressor genes and histologic differentiation in hepatocellular carcinoma.
Piao Z; Kim H; Jeon BK; Lee WJ; Park C
Cancer; 1997 Sep; 80(5):865-72. PubMed ID: 9307185
[TBL] [Abstract][Full Text] [Related]
20. Aberration of X chromosome in liver neoplasm detected by fluorescence in situ hybridization.
Liu J; Wang ZM; Zhen SF; Wu XP; Ma DX; Li ZH; Liu B; Zhao ZL; Ke Y
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):110-4. PubMed ID: 14969851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]